Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × niraparib × 1 year × Clear all

Status

Active not recruiting 33 Recruiting 22 Completed 17 Terminated 10 Withdrawn 3 Not yet recruiting 2 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-resistant Prostate Cancer 1

Interventions

zenocutuzumab 1 tucatinib 1 talquetamab 1 niraparib 1 futibatinib 1 erdafitinib 1 cemiplimab 1 adagrasib 1 Trastuzumab 1 Prednisone 1 Prednisolone 1 Capecitabine 1 Amifampridine 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05401214 2025-06-13

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Janssen Research & Development, LLC

Approved for marketing

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡